171 related articles for article (PubMed ID: 23722602)
1. Clinicopathological significance of HuR expression in gallbladder carcinoma: with special emphasis on the implications of its nuclear and cytoplasmic expression.
Sun DP; Lin CY; Tian YF; Chen LT; Lin LC; Lee SW; Hsing CH; Lee HH; Shiue YL; Huang HY; Li CF; Liang PI
Tumour Biol; 2013 Oct; 34(5):3059-69. PubMed ID: 23722602
[TBL] [Abstract][Full Text] [Related]
2. HuR cytoplasmic expression is associated with increased cyclin A expression and poor outcome with upper urinary tract urothelial carcinoma.
Liang PI; Li WM; Wang YH; Wu TF; Wu WR; Liao AC; Shen KH; Wei YC; Hsing CH; Shiue YL; Huang HY; Hsu HP; Chen LT; Lin CY; Tai C; Lin CM; Li CF
BMC Cancer; 2012 Dec; 12():611. PubMed ID: 23259573
[TBL] [Abstract][Full Text] [Related]
3. BCL6 overexpression is associated with decreased p19 ARF expression and confers an independent prognosticator in gallbladder carcinoma.
Liang PI; Li CF; Chen LT; Sun DP; Chen TJ; Hsing CH; Hsu HP; Lin CY
Tumour Biol; 2014 Feb; 35(2):1417-26. PubMed ID: 24114011
[TBL] [Abstract][Full Text] [Related]
4. Expression of the RNA-binding protein HuR and its clinical significance in human stage I and II lung adenocarcinoma.
Lauriola L; Granone P; Ramella S; Lanza P; Ranelletti FO
Histol Histopathol; 2012 May; 27(5):617-26. PubMed ID: 22419026
[TBL] [Abstract][Full Text] [Related]
5. MiR-200c and HuR in ovarian cancer.
Prislei S; Martinelli E; Mariani M; Raspaglio G; Sieber S; Ferrandina G; Shahabi S; Scambia G; Ferlini C
BMC Cancer; 2013 Feb; 13():72. PubMed ID: 23394580
[TBL] [Abstract][Full Text] [Related]
6. dCK expression correlates with 5-fluorouracil efficacy and HuR cytoplasmic expression in pancreatic cancer: a dual-institutional follow-up with the RTOG 9704 trial.
McAllister F; Pineda DM; Jimbo M; Lal S; Burkhart RA; Moughan J; Winter KA; Abdelmohsen K; Gorospe M; Acosta Ade J; Lankapalli RH; Winter JM; Yeo CJ; Witkiewicz AK; Iacobuzio-Donahue CA; Laheru D; Brody JR
Cancer Biol Ther; 2014 Jun; 15(6):688-98. PubMed ID: 24618665
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic expression of the ELAV-like protein HuR as a potential prognostic marker in esophageal squamous cell carcinoma.
Zhang C; Xue G; Bi J; Geng M; Chu H; Guan Y; Wang J; Wang B
Tumour Biol; 2014 Jan; 35(1):73-80. PubMed ID: 23873103
[TBL] [Abstract][Full Text] [Related]
8. Hu-antigen receptor (HuR) and cyclooxygenase-2 (COX-2) expression in human non-small-cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival.
Giaginis C; Alexandrou P; Tsoukalas N; Sfiniadakis I; Kavantzas N; Agapitos E; Patsouris E; Theocharis S
Tumour Biol; 2015 Jan; 36(1):315-27. PubMed ID: 25252849
[TBL] [Abstract][Full Text] [Related]
9. High expression of HuR in cytoplasm, but not nuclei, is associated with malignant aggressiveness and prognosis in bladder cancer.
Miyata Y; Watanabe S; Sagara Y; Mitsunari K; Matsuo T; Ohba K; Sakai H
PLoS One; 2013; 8(3):e59095. PubMed ID: 23516604
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of DNA fragmentation factor 45 and thyroid transcription factor 1 expression in benign and malignant lesions of the gallbladder.
Yuan Y; Yang ZL; Zou Q; Cao LF; Tan XG; Jiang S; Miao XY
Pol J Pathol; 2013 Apr; 64(1):44-51. PubMed ID: 23625600
[TBL] [Abstract][Full Text] [Related]
11. CLIC1 overexpression is associated with poor prognosis in gallbladder cancer.
Ding Q; Li M; Wu X; Zhang L; Wu W; Ding Q; Weng H; Wang X; Liu Y
Tumour Biol; 2015 Jan; 36(1):193-8. PubMed ID: 25227665
[TBL] [Abstract][Full Text] [Related]
12. HuR cytoplasmic expression is associated with increased cyclin A expression and inferior disease-free survival in patients with gastrointestinal stromal tumours (GISTs).
Wei YC; Chou FF; Li CF; Li WM; Chen YY; Lan J; Li SH; Fang FM; Hu TH; Yu SC; Eng HL; Uen YH; Tian YF; Wang JC; Huang HY
Histopathology; 2013 Oct; 63(4):445-54. PubMed ID: 23889148
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of nuclear hepatoma-derived growth factor expression in gallbladder cancer.
Tao F; Ye MF; Sun AJ; Lv JQ; Xu GG; Jing YM; Wang W
World J Gastroenterol; 2014 Jul; 20(28):9564-9. PubMed ID: 25071353
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances.
Shu GS; Lv F; Yang ZL; Miao XY
Int J Clin Oncol; 2013 Aug; 18(4):641-50. PubMed ID: 22714709
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma.
Liu DC; Yang ZL
Pathol Res Pract; 2011 Aug; 207(8):472-8. PubMed ID: 21719208
[TBL] [Abstract][Full Text] [Related]
16. Predictive and prognostic significance of cytoplasmic expression of ELAV-like protein HuR in invasive breast cancer treated with neoadjuvant chemotherapy.
Wang J; Li D; Wang B; Wu Y
Breast Cancer Res Treat; 2013 Sep; 141(2):213-24. PubMed ID: 24036660
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous/adenosquamous carcinoma and gallbladder adenocarcinoma.
Zou Q; Yang ZL; Yuan Y; Li JH; Liang LF; Zeng GX; Chen SL
World J Surg Oncol; 2013 Jun; 11():143. PubMed ID: 23782473
[TBL] [Abstract][Full Text] [Related]
18. Expression of HuR, COX-2, and survivin in lung cancers; cytoplasmic HuR stabilizes cyclooxygenase-2 in squamous cell carcinomas.
Kim GY; Lim SJ; Kim YW
Mod Pathol; 2011 Oct; 24(10):1336-47. PubMed ID: 21572400
[TBL] [Abstract][Full Text] [Related]
19. Identification of PEG10 and TSG101 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.
Liu DC; Yang ZL; Jiang S
Pathol Oncol Res; 2011 Dec; 17(4):859-66. PubMed ID: 21455631
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of nemo-like kinase (NLK) expression in patients with gallbladder cancer.
Li M; Zhang S; Wang Z; Zhang B; Wu X; Weng H; Ding Q; Tan Z; Zhang N; Mu J; Yang J; Shu Y; Bao R; Ding Q; Wu W; Cao Y; Liu Y
Tumour Biol; 2013 Dec; 34(6):3995-4000. PubMed ID: 23857283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]